ELI LILLY AND COMPANY
-0.75 | -0.20%
-0.75 | -0.20%
30d. avg volume.
365.52 - 370.64
231.87 - 375.25
News and Commentary
IPO Market Remains Quiet Ahead of Thanksgiving Holiday Week The initial public offering (IPO) market remains quiet heading into the end of the year, with only one company completing its offering last week and just one small deal planned f...
Will Twitter Go Bankrupt? Elon Musk Thinks So The world's wealthiest man, Elon Musk, has reportedly been telling staff at his newly p...
Market Update: Stocks Snap Two-Day Losing Streak on Upbeat Economic Data Stocks rallied on Wednesday, recovering from losses earlier in the week, as market participants were encouraged by upbeat economic data from the services sector. The Dow Jones In...
FDA Clears Gilead’s Remdesivir for the Treatment of Children The U.S. Food and Drug Administration (FDA) announced earlier this week that it was approving Gilead Sciences'
FDA Pulls Authorization for GSK Antibody Drug Ineffective Against New Omicron Strain The U.S. Food and Drug Administration (FDA) has withdrawn its authorization for GlaxoSmithKline plc's
Pfizer, Eli Lilly Will Curb Russian Interests, Maintain Vital Medicine Shipments Pharmaceutical giants Pfizer (...
FDA Withdraws Authorization for Regeneron and Eli Lilly Antibody Treatments For Use The U.S. Food and Drug Administration (FDA) has withdrawn its authorization for monoclonal antibody treatments manufactured by Regeneron